Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer

被引:128
作者
Blute, ML
Bergstralh, EJ
Partin, AW
Walsh, PC
Kattan, MW
Scardino, PT
Montie, JE
Pearson, JD
Slezak, JM
Zincke, H
机构
[1] Mayo Clin & Mayo Fdn, Dept Urol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Biostat, Rochester, MN 55905 USA
[3] James Buchanan Brady Urol Inst, Baltimore, MD USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[5] Univ Michigan, Urol Sect, Ann Arbor, MI 48109 USA
[6] Merck Res Labs, W Point, PA USA
关键词
prostatic neoplasms; clinical trials; prostate-specific antigen; roc curve;
D O I
10.1016/S0022-5347(05)67035-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The accurate prediction of pathological stage of prostate cancer using preoperative factors is a critical aspect of treatment. In 1997 Partin et al published tables predicting pathological stage using clinical stage, Gleason score and prostate specific antigen (PSA). We tested the validity of the Partin tables. Materials and Methods: From 1990 to 1996 inclusively 5,780 patients underwent bilateral pelvic lymphadenectomy and radical prostatectomy for prostate cancer at the Mayo Clinic. However, only 2,475 of these patients met all inclusion criteria of no preoperative treatment, known biopsy Gleason score, available preoperative PSA done either before biopsy or more than 28 days after biopsy and clinical stage T1, T2 or T3a. Among the 2,475 patients 15 had positive lymph nodes and planned prostatectomy was abandoned. The receiver operating characteristics (ROC) curve area, observed and predicted Partin rates of each pathological stage, and positive and negative predictive values were used to compare the Mayo study to the Partin tables. Results: The distribution of pathological stage was organ confined in 67% of Mayo cases versus 48% in the Partin study, extracapsular without seminal vesicle or node involvement in 18% versus 40%, seminal vesicle involvement without nodes in 9% versus 7% and were positive nodes in 6% versus 5%. Using the predicted probabilities of Partin et al the ROC curve area for predicted node positive disease was 0.84 for Mayo cases compared to an estimated 0.82 in the Partin series. The ROC curve area for predicting organ confined cancer was 0.76 for the Mayo Clinic compared to an estimated 0.73 for the Partin series. The observed rates of node positive disease were similar to those predicted (Partin) based on clinical stage, PSA and Gleason score. For organ confined disease Mayo rates were consistently higher than those predicted from the Partin series using a cut point of 0.50 or greater. Positive and negative predictive values were 0.83 and 0.49 versus 0.63 and 0.70 for the Mayo Clinic and Partin series. Conclusions: Our study provides strong evidence that sensitivity and specificity of the Partin tables for external clinical sites are similar to what was reported.
引用
收藏
页码:1591 / 1595
页数:5
相关论文
共 30 条
[1]   ANALYSIS OF RISK-FACTORS ASSOCIATED WITH PROSTATE-CANCER EXTENSION TO THE SURGICAL MARGIN AND PELVIC NODE METASTASIS AT RADICAL PROSTATECTOMY [J].
ACKERMAN, DA ;
BARRY, JM ;
WICKLUND, RA ;
OLSON, N ;
LOWE, BA .
JOURNAL OF UROLOGY, 1993, 150 (06) :1845-1850
[2]   An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level [J].
Badalament, RA ;
Miller, MC ;
Peller, PA ;
Young, DC ;
Bahn, DK ;
Kochie, P ;
ODowd, GJ ;
Veltri, RW .
JOURNAL OF UROLOGY, 1996, 156 (04) :1375-1380
[3]   ELIMINATING THE NEED FOR BILATERAL PELVIC LYMPHADENECTOMY IN SELECT PATIENTS WITH PROSTATE-CANCER [J].
BLUESTEIN, DL ;
BOSTWICK, DG ;
BERGSTRALH, EJ ;
OESTERLING, JE .
JOURNAL OF UROLOGY, 1994, 151 (05) :1315-1320
[4]   PATTERN OF FAILURE AFTER RADICAL RETROPUBIC PROSTATECTOMY FOR CLINICALLY AND PATHOLOGICALLY LOCALIZED ADENOCARCINOMA OF THE PROSTATE - INFLUENCE OF TUMOR DEOXYRIBONUCLEIC-ACID PLOIDY [J].
BLUTE, ML ;
NATIV, O ;
ZINCKE, H ;
FARROW, GM ;
THERNEAU, T ;
LIEBER, MM .
JOURNAL OF UROLOGY, 1989, 142 (05) :1262-1265
[5]   Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies [J].
Bostwick, DG ;
Wheeler, TM ;
Blute, M ;
Barrett, DM ;
MacLennan, GT ;
Sebo, TJ ;
Scardino, PT ;
Humphrey, PA ;
Hudson, MA ;
Fradet, Y ;
Miller, GJ ;
Crawford, ED ;
Blumenstein, BA ;
Mahran, HE ;
Miles, BJ .
UROLOGY, 1996, 48 (01) :47-57
[6]   DETECTION OF ORGAN-CONFINED PROSTATE-CANCER IS INCREASED THROUGH PROSTATE-SPECIFIC ANTIGEN-BASED SCREENING [J].
CATALONA, WJ ;
SMITH, DS ;
RATLIFF, TL ;
BASLER, JW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (08) :948-954
[7]   THE VOLUME OF PROSTATE-CANCER IN THE BIOPSY SPECIMEN CANNOT RELIABLY PREDICT THE QUANTITY OF CANCER IN THE RADICAL PROSTATECTOMY SPECIMEN ON AN INDIVIDUAL BASIS [J].
CUPP, MR ;
BOSTWICK, DG ;
MYERS, RP ;
OESTERLING, JE .
JOURNAL OF UROLOGY, 1995, 153 (05) :1543-1548
[8]  
DAMICO AV, 1995, CANCER, V75, P2368, DOI 10.1002/1097-0142(19950501)75:9<2368::AID-CNCR2820750929>3.0.CO
[9]  
2-#
[10]   CORE CANCER LENGTH IN ULTRASOUND-GUIDED SYSTEMATIC SEXTANT BIOPSIES - A PREOPERATIVE EVALUATION OF PROSTATE-CANCER VOLUME [J].
DIETRICK, DD ;
MCNEAL, JE ;
STAMEY, TA .
UROLOGY, 1995, 45 (06) :987-992